BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang A, Cui M, Qu H, Di J, Wang Z, Xing J, Wu F, Wu W, Wang X, Shen L, Jiang B, Su X. Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab. Oncotarget 2016;7:75293-306. [PMID: 27659529 DOI: 10.18632/oncotarget.12167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Xiang J, Liao L, Jiang B, Yuan R, Xiang Y. Target-triggered Catalytic Hairpin Assembly Activation of CRISPR/Cas12a for Amplified Detection Of Therapeutic Monoclonal Antibody. Sensors and Actuators B: Chemical 2022. [DOI: 10.1016/j.snb.2022.132578] [Reference Citation Analysis]
2 Berwanger JD, Tan HY, Jokhadze G, Bruening ML. Determination of the Serum Concentrations of the Monoclonal Antibodies Bevacizumab, Rituximab, and Panitumumab Using Porous Membranes Containing Immobilized Peptide Mimotopes. Anal Chem 2021;93:7562-70. [PMID: 33999602 DOI: 10.1021/acs.analchem.0c04903] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
3 Aloisio A, Nisticò N, Mimmi S, Maisano D, Vecchio E, Fiume G, Iaccino E, Quinto I. Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy. Viruses 2021;13:649. [PMID: 33918836 DOI: 10.3390/v13040649] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
4 Gierlich P, Mata AI, Donohoe C, Brito RMM, Senge MO, Gomes-da-Silva LC. Ligand-Targeted Delivery of Photosensitizers for Cancer Treatment. Molecules 2020;25:E5317. [PMID: 33202648 DOI: 10.3390/molecules25225317] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
5 Kaumaya PT. B-cell epitope peptide cancer vaccines: a new paradigm for combination immunotherapies with novel checkpoint peptide vaccine. Future Oncol 2020;16:1767-91. [PMID: 32564612 DOI: 10.2217/fon-2020-0224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
6 Goracci M, Pignochino Y, Marchiò S. Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy. Molecules 2020;25:E843. [PMID: 32075083 DOI: 10.3390/molecules25040843] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wu W, Wu F, Wang Z, Di J, Yang J, Gao P, Jiang B, Su X. CENPH Inhibits Rapamycin Sensitivity by Regulating GOLPH3-dependent mTOR Signaling Pathway in Colorectal Cancer. J Cancer 2017;8:2163-72. [PMID: 28819418 DOI: 10.7150/jca.19940] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
8 Salinas-Jazmín N, González-González E, Vásquez-Bochm LX, Pérez-Tapia SM, Velasco-Velázquez MA. In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis. J Vis Exp 2017. [PMID: 28518088 DOI: 10.3791/55542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]